Article: article from journal or magazin.
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Drug safety in Crohn's disease therapy
The management of Crohn's disease usually consists of a succession of short-term acute phase treatments followed by a long-term maintenance therapy. Above all the most frequent adverse events and the data on the long-term safety of the therapeutic arsenal available to the physician will be taken into consideration. The drugs described in this article include 5-ASA compounds, antibiotics (metronidazole, ciprofloxacin and rifaximin), corticosteroids (budesonide, prednisone and equivalents), thiopurines (azathioprine and 6-mercaptopurine), methotrexate, anti-tumor necrosis factor inhibitors (infliximab, adalimumab, certolizumab), natalizumab, anticalcineurin inhibitors (cyclosporine, tacrolimus) and mycophenolate mofetil. [Ed.]
Adrenal Cortex Hormones, Adrenal Cortex Hormones/standards, Adrenal Cortex Hormones/therapeutic use, Anti-Bacterial Agents, Anti-Bacterial Agents/standards, Anti-Bacterial Agents/therapeutic use, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal/standards, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Crohn Disease, Crohn Disease/drug therapy, Dose-Response Relationship, Drug, Humans, Immunosuppressive Agents, Immunosuppressive Agents/standards, Immunosuppressive Agents/therapeutic use, Risk Factors, Safety
Web of science
Last modification date